<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39384321</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2755-9734</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>BMJ mental health</Title><ISOAbbreviation>BMJ Ment Health</ISOAbbreviation></Journal><ArticleTitle>Systematic review of interventions for mental health, cognition and psychological well-being in long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e301133</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjment-2024-301133</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This systematic review aims to identify and synthesise the publicly available research testing treatments for mental health, cognition and psychological well-being in long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The following databases and repositories were searched in October-November 2023: Medline, Embase, APA PsycINFO, Cumulative Index to Nursing and Allied Health Literature, China National Knowledge Internet, WANFANG Data, Web of Science's Preprint Citation Index, The Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform. Articles were selected if they described participants with long COVID symptoms at least 4 weeks after SAR-CoV-19 infection, reported primary outcomes on mental health, cognition and/or psychological well-being, and were available with at least an English-language summary. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for systematic reviews were followed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-three documents representing 31 studies were included. Seven tested psychosocial interventions, five pharmaceutical interventions, three natural supplement interventions, nine neurocognitive interventions, two physical rehabilitation interventions and five integrated interventions. While some promising findings emerged from randomised controlled trials, many studies were uncontrolled; a high risk of bias and insufficient reporting were also frequent.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The published literature on treatments for mental health, cognition and psychological well-being in long COVID show that the interventions are highly heterogeneous and findings are inconclusive to date. Continued scientific effort is required to improve the evidence base. Regular literature syntheses will be required to update and educate clinicians, scientists, interventionists and the long COVID community.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawke</LastName><ForeName>Lisa D</ForeName><Initials>LD</Initials><Identifier Source="ORCID">0000-0003-1108-9453</Identifier><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada lisa.hawke@camh.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Anh T P</ForeName><Initials>ATP</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Eric E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Harbin Medical University, Harbin, Heilongjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deuville</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goulding</LastName><ForeName>Suzie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ski</LastName><ForeName>Chantal F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossell</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Swinburne University of Technology, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0001-8518-6307</Identifier><AffiliationInfo><Affiliation>Queen's University Belfast School of Nursing and Midwifery, Belfast, Northern Ireland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodak</LastName><ForeName>Terri</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strudwick</LastName><ForeName>Gillian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Tasmania, Hobart, Tasmania, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Ment Health</MedlineTA><NlmUniqueID>9918521385306676</NlmUniqueID><ISSNLinking>2755-9734</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="Y">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083626" MajorTopicYN="N">Psychosocial Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000092862" MajorTopicYN="N">Psychological Well-Being</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword></KeywordList><CoiStatement>Competing interests: DC has received grant for research from Servier, Boehringer Ingelheim; travel support and honoraria for talks and consultancy from Servier, Seqirus, Lundbeck. He is a founder of the Optimal Health Programme (OHP), and holds 50% of the intellectual property for the programme; and is part owner of Clarity Healthcare. He does not knowingly have stocks or shares in any pharmaceutical company. Other authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384321</ArticleId><ArticleId IdType="pmc">PMC11474695</ArticleId><ArticleId IdType="doi">10.1136/bmjment-2024-301133</ArticleId><ArticleId IdType="pii">bmjment-2024-301133</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . Geneva, Switzerland:: World Health Organization; 2024. Post covid-19 condition (long covid)https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation Available.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennelly CE, Nguyen ATP, Sheikhan NY, et al. The lived experience of long COVID: A qualitative study of mental health, quality of life, and coping. PLoS One. 2023;18:e0292630. doi: 10.1371/journal.pone.0292630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0292630</ArticleId><ArticleId IdType="pmc">PMC10575511</ArticleId><ArticleId IdType="pubmed">37831706</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur . 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, Nguyen ATP, Sheikhan NY, et al. Swept under the carpet: a qualitative study of patient perspectives on Long COVID, treatments, services, and mental health. BMC Health Serv Res. 2023;23:1088. doi: 10.1186/s12913-023-10091-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-023-10091-9</ArticleId><ArticleId IdType="pmc">PMC10568931</ArticleId><ArticleId IdType="pubmed">37821939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, Nguyen ATP, Ski CF, et al. Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Psychol Med. 2022;52:2426&#x2013;40. doi: 10.1017/S0033291722002203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722002203</ArticleId><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jabr H, Hawke LD, Thompson DR, et al. Interventions to support mental health in people with long COVID: a scoping review. BMC Public Health. 2023;23:1186. doi: 10.1186/s12889-023-16079-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16079-8</ArticleId><ArticleId IdType="pmc">PMC10280822</ArticleId><ArticleId IdType="pubmed">37340400</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Staniszewska S, Brett J, Simera I, et al. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. BMJ. 2017;358:j3453. doi: 10.1136/bmj.j3453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j3453</ArticleId><ArticleId IdType="pmc">PMC5539518</ArticleId><ArticleId IdType="pubmed">28768629</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc . 2006;2006:359&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839740</ArticleId><ArticleId IdType="pubmed">17238363</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell SM. Filter to retrieve studies related to long covid in the OVID medline database: geoffrey &amp; robyn sperber health sciences library. University of Alberta. 2023. https://docs.google.com/document/d/1RrEgiFH1M1k_V-S-xBbXrMZrXwaAJ7RO0Baa-U_9dL0/edit#heading=h.v97m5qxqnbli Available.</Citation></Reference><Reference><Citation>All Clinical Trials - MEDLINE, Embase  . Ottawa:: CADTH; 2024. CADTH search filters database.https://searchfilters.cadth.ca/link/117 Available.</Citation></Reference><Reference><Citation>Higgins JPT, Savovi&#x107; J, Page MJ, et al. In: Cochrane handbook for systematic reviews of interventions. Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane; 2021. Chapter 8: assessing risk of bias in a randomized trial.</Citation></Reference><Reference><Citation>Munn Z, Barker TH, Moola S, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth . 2020;18:2127&#x2013;33. doi: 10.11124/JBISRIR-D-19-00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.11124/JBISRIR-D-19-00099</ArticleId><ArticleId IdType="pubmed">33038125</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Munn Z, Tufanaru C, et al. In: JBI Manual for Evidence Synthesis. Aromatarisx EZM, editor. JBI; 2020. Chapter 7: systematic reviews of etiology and risk.</Citation></Reference><Reference><Citation>Bogucki OE, Sawchuk CN. Cognitive processing therapy for posttraumatic stress disorder due to COVID-19-related traumas: A case study. Psychol Serv. 2023;20:533&#x2013;7. doi: 10.1037/ser0000630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/ser0000630</ArticleId><ArticleId IdType="pubmed">35113624</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth D, Br&#xe4;scher A-K, Tholl S, et al. Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial. Psychol Med. 2024;54:1122&#x2013;32. doi: 10.1017/S0033291723002921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291723002921</ArticleId><ArticleId IdType="pubmed">37842765</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwan K, Collett H, Nairn J, et al. The Feasibility and Impact of Practising Online Forest Bathing to Improve Anxiety, Rumination, Social Connection and Long-COVID Symptoms: A Pilot Study. IJERPH . 2022;19:14905. doi: 10.3390/ijerph192214905.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192214905</ArticleId><ArticleId IdType="pmc">PMC9691063</ArticleId><ArticleId IdType="pubmed">36429623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikrah N, Bahari F, Shiri A. Effectiveness of the acceptance and commitment therapy on resilience and quality of life in patients with post-acute COVID-19 syndrome. Appl Nurs Res. 2023;73:151723. doi: 10.1016/j.apnr.2023.151723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apnr.2023.151723</ArticleId><ArticleId IdType="pubmed">37722791</ArticleId></ArticleIdList></Reference><Reference><Citation>Skilbeck L. Patient-led integrated cognitive behavioural therapy for management of long COVID with comorbid depression and anxiety in primary care - A case study. Chronic Illn. 2022;18:691&#x2013;701. doi: 10.1177/17423953221113605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953221113605</ArticleId><ArticleId IdType="pubmed">35821571</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, van Bommel J, Wils E-J, et al. Intensive Care Unit-Specific Virtual Reality for Critically Ill Patients With COVID-19: Multicenter Randomized Controlled Trial. J Med Internet Res. 2022;24:e32368. doi: 10.2196/32368.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/32368</ArticleId><ArticleId IdType="pmc">PMC8812141</ArticleId><ArticleId IdType="pubmed">34978530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright H, Turner A, Ennis S, et al. Digital Peer-Supported Self-Management Intervention Codesigned by People With Long COVID: Mixed Methods Proof-of-Concept Study. JMIR Form Res . 2022;6:e41410. doi: 10.2196/41410.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/41410</ArticleId><ArticleId IdType="pmc">PMC9578526</ArticleId><ArticleId IdType="pubmed">36166651</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavendish BA, Lima A, Bertola L, et al. Combination of transcranial direct current stimulation with online cognitive training improves symptoms of Post-acute Sequelae of COVID-19: A case series. Brain Stimul. 2022;15:1375&#x2013;7. doi: 10.1016/j.brs.2022.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.008</ArticleId><ArticleId IdType="pmc">PMC9528061</ArticleId><ArticleId IdType="pubmed">36202328</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Molina A, Garc&#xed;a-Carmona S, Espi&#xf1;a-Bou M, et al. Rehabilitaci&#xf3;n neuropsicol&#xf3;gica en el s&#xed;ndrome post-COVID-19: resultados de un programa cl&#xed;nico y seguimiento a los 6 meses. Neurol. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9345851</ArticleId><ArticleId IdType="pubmed">35936979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausswirth C, Schmit C, Rougier Y, et al. Positive Impacts of a Four-Week Neuro-Meditation Program on Cognitive Function in Post-Acute Sequelae of COVID-19 Patients: A Randomized Controlled Trial. Int J Environ Res Public Health . 2023;20:1361. doi: 10.3390/ijerph20021361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021361</ArticleId><ArticleId IdType="pmc">PMC9858974</ArticleId><ArticleId IdType="pubmed">36674117</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitl D, Schneeberger T, Jarosch I, et al. Effects of cranial electrical stimulation in patients with post-covid syndrome with and without anxiety symptoms- a pilot randomized controlled trial. American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC; 2023.</Citation></Reference><Reference><Citation>&#x141;ucko&#x15b; M, Cieleb&#x105;k K, Kami&#x144;ski P. EEG NEUROFEEDBACK IN THE TREATMENT OF COGNITIVE DYSFUNCTIONS AFTER THE INFECTION OF SARS-COV-2 AND LONG COVID-19. Acta Neuropsychol. 2021;19:361&#x2013;72. doi: 10.5604/01.3001.0015.2464.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/01.3001.0015.2464</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, Sato A, Shichi M, et al. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J Psychiatr. 2023;81:103438. doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference><Reference><Citation>Orend&#xe1;&#x10d;ov&#xe1; M, Kva&#x161;&#x148;&#xe1;k E, Vr&#xe1;nov&#xe1; J. Effect of neurofeedback therapy on neurological post-COVID-19 complications (A pilot study) PLoS One. 2022;17:e0271350. doi: 10.1371/journal.pone.0271350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0271350</ArticleId><ArticleId IdType="pmc">PMC9328527</ArticleId><ArticleId IdType="pubmed">35895740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabel BA, Zhou W, Huber F, et al. Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restor Neurol Neurosci. 2021;39:393&#x2013;408. doi: 10.3233/RNN-211249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-211249</ArticleId><ArticleId IdType="pmc">PMC8764598</ArticleId><ArticleId IdType="pubmed">34924406</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana K, Fran&#xe7;a E, Sato J, et al. Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2023;16:100&#x2013;7. doi: 10.1016/j.brs.2023.01.1672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.1672</ArticleId><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal K, Cavendish B, Lima AL, et al. Combination of transcranial direct current stimulation with online cognitive training improves symptoms of Post-acute Sequelae of COVID-19: a case series. Brain Stimul. 2023;16:232. doi: 10.1016/j.brs.2023.01.348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.348</ArticleId><ArticleId IdType="pmc">PMC9528061</ArticleId><ArticleId IdType="pubmed">36202328</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P, Camaioni A, Marra P, et al. Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study. Cells . 2022;11:2552. doi: 10.3390/cells11162552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162552</ArticleId><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Karosanidze I, Kiladze U, Kirtadze N, et al. Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial. Pharmaceuticals (Basel) 2022;15:345. doi: 10.3390/ph15030345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15030345</ArticleId><ArticleId IdType="pmc">PMC8953947</ArticleId><ArticleId IdType="pubmed">35337143</ArticleId></ArticleIdList></Reference><Reference><Citation>Young TP, Erickson JS, Hattan SL, et al. A Single-Blind, Randomized, Placebo Controlled Study to Evaluate the Benefits and Safety of Endourage Targeted Wellness Formula C Sublingual +Drops in People with Post-Acute Coronavirus Disease 2019 Syndrome. Cannabis Cannabinoid Res. 2024;9:282&#x2013;92. doi: 10.1089/can.2022.0135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/can.2022.0135</ArticleId><ArticleId IdType="pubmed">36252151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogolepova AN, Osinovskaya NA, Kovalenko EA, et al. Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches. RJTAO . 2021;13:88&#x2013;93. doi: 10.14412/2074-2711-2021-4-88-93.</Citation><ArticleIdList><ArticleId IdType="doi">10.14412/2074-2711-2021-4-88-93</ArticleId></ArticleIdList></Reference><Reference><Citation>Esin RG, Khayrullin IK, Esin OR, et al. Effectiveness of the anxiolytic Anvifen in the treatment of post-COVID brain fog. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122:101&#x2013;5. doi: 10.17116/jnevro2022122081101.</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/jnevro2022122081101</ArticleId><ArticleId IdType="pubmed">36036410</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Phan L, Kwan ATH, et al. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain (Bacau) 2023 doi: 10.1093/brain/awad377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad377</ArticleId><ArticleId IdType="pubmed">37936330</ArticleId></ArticleIdList></Reference><Reference><Citation>Putilina MV, Mutovina ZY, Kurushina OV, et al. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program. Neurosci Behav Physiol . 2022;52:836&#x2013;41. doi: 10.1007/s11055-022-01307-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11055-022-01307-2</ArticleId><ArticleId IdType="pmc">PMC9596337</ArticleId><ArticleId IdType="pubmed">36311877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E, Spengler RN, Ignatowski TA, et al. Rapid improvement in severe long COVID following perispinal etanercept. Curr Med Res Opin. 2022;38:2013&#x2013;20. doi: 10.1080/03007995.2022.2096351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2096351</ArticleId><ArticleId IdType="pubmed">35791687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat AM, Sasson E, Wang Z, et al. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report. J Med Case Rep. 2022;16:80. doi: 10.1186/s13256-022-03287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Brough DN, Abel S, Priddle L. A service evaluation of a community project combining psychoeducation and mind-body complementary approaches to support those with long covid in the UK. Eur J Integr Med. 2022;55:102182. doi: 10.1016/j.eujim.2022.102182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eujim.2022.102182</ArticleId><ArticleId IdType="pmc">PMC9392656</ArticleId><ArticleId IdType="pubmed">36035093</ArticleId></ArticleIdList></Reference><Reference><Citation>Compagno S, Palermi S, Pescatore V, et al. Physical and psychological reconditioning in long COVID syndrome: Results of an out-of-hospital exercise and psychological - based rehabilitation program. Int J Cardiol Heart Vasc. 2022;41:101080. doi: 10.1016/j.ijcha.2022.101080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2022.101080</ArticleId><ArticleId IdType="pmc">PMC9286763</ArticleId><ArticleId IdType="pubmed">35854691</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, Owles H, McVey S, et al. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir Med. 2022;10:851&#x2013;62. doi: 10.1016/S2213-2600(22)00125-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00125-4</ArticleId><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="pubmed">35489367</ArticleId></ArticleIdList></Reference><Reference><Citation>Raunkiaer M, Joergensen DS, Rasmussen A, et al. Experiences of improvement of everyday life following a rehabilitation programme for people with long-term cognitive effects of COVID-19: Qualitative study. J Clin Nurs. 2024;33:137&#x2013;48. doi: 10.1111/jocn.16739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16739</ArticleId><ArticleId IdType="pubmed">37222026</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, et al. Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. Sci Rep. 2023;13:7943. doi: 10.1038/s41598-023-35058-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35058-y</ArticleId><ArticleId IdType="pmc">PMC10187508</ArticleId><ArticleId IdType="pubmed">37193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Oliv&#xe1;n-Bl&#xe1;zquez B, Le&#xf3;n-Herrera S, et al. Effectiveness of recovery app to improve the quality of life of long covid patients: a 6-month follow-up randomized clinical trial. Primary Care Research. doi: 10.1101/2023.08.30.23294831. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.30.23294831</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuijpers P, Weitz E, Cristea IA, et al. Pre-post effect sizes should be avoided in meta-analyses. Epidemiol Psychiatr Sci. 2017;26:364&#x2013;8. doi: 10.1017/S2045796016000809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2045796016000809</ArticleId><ArticleId IdType="pmc">PMC6998624</ArticleId><ArticleId IdType="pubmed">27790968</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>